# A Study of GNC-077 in Patients With Locally Advanced or Metastatic Non-small-cell Lung Cancer and Other Solid Tumors

> **NCT06612840** · PHASE1 · RECRUITING · sponsor: **Sichuan Baili Pharmaceutical Co., Ltd.** · enrollment: 20 (estimated)

## Conditions studied

- Non-small Cell Lung Cancer
- Solid Tumor

## Interventions

- **DRUG:** GNC-077

## Key facts

- **NCT ID:** NCT06612840
- **Lead sponsor:** Sichuan Baili Pharmaceutical Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-10-16
- **Primary completion:** 2026-10
- **Final completion:** 2026-10
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2026-01-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06612840

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06612840, "A Study of GNC-077 in Patients With Locally Advanced or Metastatic Non-small-cell Lung Cancer and Other Solid Tumors". Retrieved via AI Analytics 2026-07-18 from https://api.ai-analytics.org/clinical/NCT06612840. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*